5-Year Impact Factor: 0.9
Volume 35, 12 Issues, 2025
  Clinical Practice Article     July 2025  

Factors Influencing Glycaemic Control in Adolescents with Type I Diabetes: Cross-Sectional Analysis of Individual and Parental Factors

By Fozia Memon, Muzna Arif, Maryam Haider, Muhammad Farrukh Qazi, Imran Nisar, Khadija Nuzhat Humayun

Affiliations

  1. Department of Paediatrics, Endocrinology, and Child Health, The Aga Khan University Hospital, Karachi, Pakistan
doi: 10.29271/jcpsp.2025.07.908

ABSTRACT
Objective: To identify modifiable risk factors that influence glycaemic control in Type I Diabetic adolescents.
Study Design: A cross-sectional analytical study.
Place and Duration of the Study: Outpatient clinics, Department of Paediatric, Endocrinology, and Child Health, The Aga Khan University Hospital, Karachi, Pakistan, from January 2020 to December 2022.
Methodology: This study included 246 randomly selected adolescents aged 10-18 years with Type I Diabetes on multiple daily injections. Data were gathered through face-to-face interviews and scrutiny of medical records. The research employed multiple logistic regression analysis to identify and understand the factors associated with glycaemic control.
Results: Of the 246 adolescents (mean age 13.7 years, range 10-18 years), there were 56% females and 43% males. The average duration of Diabetes diagnosis was 5.1 years (range 1-15 years). HbA1c levels reflecting poor glycaemic control (HbA1c >7.5%) were found in 71% of the study population. Multivariate analysis showed poor compliance with diet (OR: 2.2, CI: 0.9, 4.6, p = 0.056), infrequent clinic visits (OR: 3.32, CI: 1.63, 6.79, p = 0.001), and number of insulin injections per day (OR: 0.12, CI: 0.02, 0.93, p = 0.043) were significantly associated with increased odds of suboptimal glycaemic control.
Conclusion: This study concluded that glycaemic control in the adolescent population was suboptimal. For optimal glycaemic control, treating physicians should concentrate on the modifiable factors responsible for glycaemic control.

Key Words: Type I Diabetes mellitus, Adolescents, Glycaemic control, Risk factors.

INTRODUCTION

Hyperglycaemia is a major risk factor for the development of long-term complications in Type I Diabetes (T1D). HbA1c is an index of metabolic control and a measure of long-term diabetic complications. Data from the DCCT and the U.K. Prospective Diabetes Study show that HbA1c is strongly correlated with adverse outcome risks.1 In the T1D exchange clinic registry, which included 25,833 individuals with T1D in the USA, the poorest control was observed in the age group of 13–25 years.2 Similarly, another study found that the highest percentage of people with an HbA1c level ≥58 mmol/mol (≥7.5%) was among individuals aged 15-24 years in Ireland, with a proportion of 91.1%.3
 

Adolescents with diabetes face various challenges that can make it difficult to adhere to their treatment plan. Pubertal physiology, developmental habits, changes in family dynamics, socioeconomic status, and perceived social pressure can all contribute to insulin resistance and exacerbate difficulties in managing diabetes.4-6

Achieving good metabolic control is crucial for children with diabetes to avoid complications later in life. Despite advancements in diabetes technology, therapies, and more ambitious glycaemic targets, a recent study revealed that contemporary youth and young adults with T1D in the U.S. exhibit poorer glycaemic control compared to earlier cohorts.7 Moreover, the study on role of physical activity among youth proves that better glycaemic control is significantly associated with higher physical activity.8

Managing T1D is even more challenging in developing countries such as Pakistan, where the cost of medications and insulin pumps is a significant issue, and health insurance coverage and medical resources in rural as well as urban areas are limited. Despite these challenges, healthcare providers are responsible for ensuring that individuals with diabetes comply with treatment plans and address any modifiable risk factors that may lead to poor blood sugar control. This study aimed to identify factors that impact blood sugar regulation in adolescents with T1D, allowing healthcare providers to focus on addressing these underlying issues and improving care for adolescents with T1D.

METHODOLOGY

A cross-sectional analytical study was carried out at the out- patient diabetes clinic of the Aga Khan University Hospital, Karachi, Pakistan, from January 2020 to December 2022. Adolescents aged between 10-18 years were included in the study.9 The children under 10 years, children with Type II diabetes (T2D), and other forms of secondary diabetes (e.g. Thalassaemia-associated diabetes and monogenic diabetes) were excluded from the study. The study involved interviewing the participants using a structured questionnaire to collect data on socio-demographic and risk factor variables, including age, gender, residence, household income, and socioeconomic status of the family. All participants had a documented diagnosis of T1D after six months of age. The criteria for diagnosis as per the International Society for Paediatric and Adolescent Diabetes (ISPAD) guidelines were HbA1C >6.5%, fasting glucose >126 mg/dl, and random glucose >200 mg/dl.10 Glycaemic control was further categorised into strict (HbA1c ≤7.5%) and poor control (HbA1c >7.5%) groups.

The study defined dietary compliance as adherence to a balanced diet recommended by a nutritionist, diabetic nurse, or paediatric endocrinologist following the ISPAD recommendations. Compliance with diet was further subcategorised into two categories: Strictly adhering to the recommended diet, and not or only occasionally adhering to it. The frequency of blood glucose monitoring was subcategorised into two categories: Monitoring less than or equal to two times per day, and monitoring more than or equal to three times per day. The number of clinic visits per year was categorised as less than or equal to two times per year and more than or equal to three times per year. Compliance with insulin administration with MDI was assessed by the number of insulin injections per day, subcategorised into one to three injections per day, and four injections per day. Daily physical activity, defined as moderate intensity for 20-25 minutes according to the Centres for Disease Control and Prevention (CDC) recommendation, was categorised as strictly adhering to the recommendation, and not or only occasionally adhering to it. Parental risk factors, including adherence to a balanced diet, involvement in glucose monitoring, and active participation, and encouragement in insulin insertion, were assessed by YES and NO.

The sample size was calculated using the following formula n = (Z2 p (1–p)/ε2, which resulted in an estimated minimum sample size of 246. Data analysis was conducted using the Stata software, quantitative variables were presented as mean and standard deviation, while qualitative variables were described using frequency and percentage. The differences in proportions of categorical variables between two or more groups were analysed using the Chi-square test. The prevalence odds ratio was calculated. Additionally, a multivariable logistic regression model was used to identify factors that affect glycaemic control. A statistical significance was set at a p-value of <0.05 for all analyses.

RESULTS

A total of 246 participants were enrolled, consisting of 108 (43.9%) males and 138 (56.1%) females. The median age at diagnosis was 13.7 years (range 10-18 years), and the median duration of diabetes was 5.1 years (range 1-15 years). The mean HbA1c of the study cohort was 8.6 ± 1.56%. Of the total participants, 70 (28.5%) had good glycaemic control (HbA1c ≤7.5%), while 176 (71.5%) had poor glycaemic control (HbA1c >7.5%) (Table I).

When analysing males and females separately based on their glycaemic control, it was found that 34 (48.6%) males and 36 (51.4%) females had good glycaemic control (HbA1c ≤7.5%). Conversely, 74 (42%) males and 102 (58%) females had poor glycaemic control (HbA1c >7.5%) (Table II). To investigate the factors that could be associated with better glycaemic control, individual characteristics were analysed among children with adequate (HbA1c ≤7.5%) and inadequate (HbA1c >7.5%) glycaemic control.

Table I: Demographic characteristics of adolescents with T1D by HbA1C levels.

Demographic characteristics

n (%)

 

n = 246

Age, years (mean ± SD) (10-18 years)

13.77 ± 2.85

      ≤14 years

139 (56.5%)

      >14 years

107 (43.5%)

Gender

 

      Male

108 (43.9%)

      Female

138 (56.1%)

Family structure

 

      Single parent

32 (13.0%)

      Two (both parents)

214 (87.0%)

Household income, PKR

 

      <50,000

52 (21.1%)

      ≥50,000

194 (78.9%)

Caretaker

 

      Mother

223 (90.7%)

      Father or others

23 (9.3%)

Duration of diabetes

 

      ≤5 years

152 (61.8%)

      >5 years

94 (38.2%)

HbA1c

 

      ≤7.5%

70 (28.5%)

      >7.5%

176 (71.5%)

Compliance with diet

 

      Strictly

184 (74.8%)

      No or occasionally

62 (25.2%)

Insulin frequency/day

 

      Not using

4 (1.63%)

      1-3 per day

32 (13.01%)

      4 per day

210 (85.37%)

Frequency of blood glucose monitoring/day

 

      2 or less

50 (20.3%)

      3 or more

196 (79.7%)

Hospital admission last year

 

      Yes

34 (13.8%)

      No

212 (86.2%)

No. of clinic visits/year

 

      2 or less visits

99 (40.2%)

      3 or more visits

147 (59.8%)

Physical activity

 

      Yes

165 (67.1%)

      No

81 (32.9%)

Parental adherence

 

     Yes

202 (82.1%)

     No

44 (17.9%)

Table II: Individual and parental characteristics with comparison to glycaemic control.

Baseline characteristics by HbA1c

HbA1c ≤7.5

HbA1c >7.5

POR (CI)

p-value

OR (CI)

p-value

(n = 70)

(n = 176)

Age, years (mean ± SD)

13.4 ± 2.7

13.8 ± 2.9

1.06 (0.96, 1.16)

0.274

-

 

      ≤14 years

43 (61.4%)

96 (54.5%)

Reference

 

 

 

      >14 years

27 (38.6%)

80 (45.5%)

1.33 (0.75, 2.33)

0.326

-

 

Gender

 

 

 

 

 

 

      Male

34 (48.6%)

74 (42.0%)

0.77 (0.44, 1.34)

0.353

-

 

      Female

36 (51.4%)

102 (58.0%)

Reference

 

 

 

Family structure

 

 

 

 

 

 

      Single parent

10 (14.3%)

22 (12.5%)

0.86 (0.38, 1.92)

0.707

-

 

      Two (both parents)

60 (85.7%)

154 (87.5%)

Reference

 

 

 

Household income, PKR

 

 

 

 

 

 

      <50,000

9 (12.9%)

43 (24.4%)

2.19 (1.04, 4.78)

0.049

-

 

      ≥50,000

61 (87.1%)

133 (75.6%)

Reference

 

 

 

Caretaker

 

 

 

 

 

 

      Mother

64 (91.4%)

159 (90.3%)

Reference

 

 

 

      Father or others

6 (8.6%)

17 (9.7%)

1.14 (0.43, 3.02)

0.792

-

 

Duration of diabetes

 

 

 

 

 

 

      ≤5 years

48 (68.6%)

104 (59.1%)

Reference

 

 

 

      >5 years

22 (31.4%)

72 (40.9%)

1.51 (0.84, 2.72)

0.169

-

 

Compliance with diet

 

 

 

 

 

 

      Strictly

60 (85.7%)

124 (70.5%)

Reference

 

Reference

 

      No. or occasionally

10 (14.3%)

52 (29.5%)

2.52 (1.20, 5.29)

0.015

2.21 (0.98, 4.65)

0.056

Insulin frequency/day, (n = 242)

 

 

 

 

 

 

      1-3 per day

1 (1.5%)

31 (17.8%)

Reference

 

Reference

 

      4 per day

67 (98.5%)

143 (82.2%)

0.07 (0.01, 0.51)

0.009

0.12 (0.02, 0.93)

0.043

Frequency of blood glucose monitoring/day

 

 

 

 

 

 

      2 or less

6 (8.6%)

44 (25.0%)

3.56 (1.44, 8.78)

0.006

-

 

      3 or more

64 (91.4%)

132 (75.0%)

Reference

 

 

 

Hospital admission last year

 

 

 

 

 

 

      Yes

8 (11.4%)

26 (14.8%)

1.34 (0.58, 3.13)

0.494

-

 

      No

62 (88.6%)

150 (85.2%)

Reference

 

 

 

No. of clinic visits/year

 

 

 

 

 

 

      2 or less visits

13 (18.6%)

86 (48.9%)

4.19 (2.14, 8.19)

<0.001

3.32 (1.63, 6.79)

0.001

      3 or more visits

57 (81.4%)

90 (51.1%)

Reference

 

Reference

 

Physical activity

 

 

 

 

 

 

      Yes

51 (72.9%)

114 (64.8%)

Reference

 

 

 

      No

19 (27.1%)

62 (35.2%)

1.46 (0.79, 2.70)

0.225

-

 

Parental adherence

 

 

 

 

 

 

     Yes

65 (92.9%)

137 (77.8%)

Reference

 

 

 

     No

5 (7.1%)

39 (22.2%)

3.70 (1.39, 9.82)

0.009

-

 

The percentage of glycaemic control was found to be higher in children who maintained strict diet control, with an adjusted odds ratio of 2.21, CI (0.98, 4.65) and a p-value of <0.056. Furthermore, it was higher among subjects who regularly used insulin compared to those who did not, with an adjusted odds ratio of 0.12, CI (0.02, 0.93) and a p-value of <0.043. Additionally, children who attended clinics regularly (at least four times per year) had better glycaemic control than those who did not, with an adjusted odds ratio of 3.6, CI (1.85, 7.28) and a p-value of <0.001.

DISCUSSION

The current study found that adolescents with T1D had high levels of HbA1c, with a mean level of 8.6%, ranging from 6-13.5%. This is comparable to the findings from Scotland (DIABAUD2) and Thailand, which reported mean HbA1C levels of 9.1% and 9.2%, respectively.11,12 However, studies in deve-loping countries such as Kenya and Tanzania reported even higher mean HbA1c levels, suggesting that differences in access to healthcare and specialists may play a role in glycae-mic control.13

Dietary compliance is an essential factor in glycaemic management, especially for adolescents with T1D who may be vulnerable to disordered eating habits. This study found that poor glycaemic control was more common among adolescents with poor dietary compliance, which is consistent with findings from other studies.14 In addition to poor dietary habits, teenagers with T1D often face psychosocial hurdles such as low mood, anxiety, and depression, which can lead to skipping doses of insulin. This study found that skipping doses of insulin was a significant contributor to poor glycaemic control. Previous studies have also reported similar findings, with evidence suggesting that a regimen of three or more daily injections is more effective than a two-daily injection regi-men.15 Resolving psychological issues and tailoring treatment to the adolescents’ lifestyle can help improve adherence to insulin.

Another key-study finding is the significant association bet-ween the frequency of clinic visits and glycaemic control, which is consistent with previous research by Kaufman et al. They recommend that quarterly clinic visits should be ensured for adequate glycaemic control in adolescents with T1D.16

Although the development of pumps and CGM in recent years has certainly improved the management of T1D, particularly in children.17 However, the authors still believe that treatment compliance and adherence are still critical factors for success-ful diabetes control. Therefore, the focus is on identifying and addressing modifiable factors that can improve glycaemic control in resource-limited settings. By prioritising these factors, the authors hope to promote better treatment comp-liance and help patients achieve better diabetes outcomes despite resource constraints.

This was a single-centre study, catering to the higher socio-economic class, and therefore not truly representative of the actual Pakistani community, which is composed of people from the lower and lower-middle classes. The second biggest weakness is the study's cross-sectional design, which prevents inferences about direct causal relations. Recall bias may exist in data that parents and teenagers self-reported. The relation of a few variables that influence glycaemic control, including income, parental adherence, frequency of blood glucose monitoring, and physical activity, is still not clear in this study. Further prospective research is required to establish the causal link between these parameters and glycaemic control.

CONCLUSION

This study concluded that glycaemic control in this adolescent population is poor. For optimal glycaemic control, treating physicians should concentrate on the risk factors associated with poor glycaemic control in every clinic visit. Overall, these results underscore the importance of a comprehensive approach to diabetes care that considers not only medical treatment but also patient education, support, and follow-up care.

ETHICAL  APPROVAL:
Ethical approval for this study was obtained from the Institutional Review Board and Ethical Committee of the Aga Khan University Hospital, Karachi, Pakistan (ERC# 2019- 1967-5864).

PATIENTS’  CONSENT:
All patients provided written informed consent, while child participants above 16 years of age provided their assent.

COMPETING  INTEREST:
The authors declared no conflict of interest.

AUTHORS’  CONTRIBUTION:
FM: Conception or design of the work and interpretation of the data.
MA, MH: Conception or design of the work.
MFQ: Analysis and interpretation of the data.
IN, KNH: Drafting of the work and critically revising the manuscript for important intellectual content.
All authors approved the final version of the manuscript to be published.

REFERENCES

  1. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbA1c: Analysis of glucose profiles and HbA1c in the Diabetes control and complications trial. Diabetes Care 2002; 25(2):275-8. doi: 10.2337/diacare.25.2.275.
     
  2. Beck RW, Tamborlane WV, Bergenstal RM, Miller KM, DuBose SN, Hall CA, et al. The T1D exchange clinic registry. J Clin Endocrinol Metab 2012; 97(12):4383-9. doi: 10.1210/jc.2012-1561.
  3. McKnight J, Wild S, Lamb M, Cooper M, Jones T, Davis E, et al. Glycaemic control of Type I diabetes in clinical practice early in the 21st century: An international comparison. Diabet Med 2015; 32(8):1036-50. doi: 10.1111/dme. 12676.
  4. Alassaf A, Odeh R, Gharaibeh L, Ibrahim S, Ajlouni K. Impact of socioeconomic characteristics on metabolic control in children with type 1 diabetes in a developing country. J Clin Res Pediatr Endocrinol 2019; 11(4):358. doi: 10.4274/jcrpe.galenos.2019.2019.0014.
  5. Nielsen NF, Gaulke A, Eriksen TM, Svensson J, Skipper N. Socioeconomic inequality in metabolic control among children with Type I Diabetes: A nationwide longitudinal study of 4,079 Danish children. Diabetes Care 2019; 42(8): 1398-405. doi: 10.2337/dc19-0184.
  6. Khadilkar A, Oza C. Glycaemic control in youth and young adults: Challenges and solutions. Diabetes Metab Syndr Obes 2022; 15:121-9. doi: 10.2147/DMSO.S304347.
  7. Malik F, Sauder KA, Isom S, Roberts AJ, Mayer EJ, Dolan LM, et al. editors. Trends in glycaemic control among youth with diabetes: The search for diabetes in youth study. Diabetes Care 2020; 45(2):285-94. doi: 10.2337/dc21-0507.
  8. Aljawarneh YM, Wood GL, Wardell DW, Al-Jarrah MD. The associations between physical activity, health-related quality of life, regimen adherence, and glycaemic control in adolescents with Type I Diabetes: A cross-sectional study. Prim Care Diabetes 2023; 17(4):392-400. doi: 10.1016/j. pcd.2023.04.003.
  9. Sacks D. Age limits and adolescents. Paediatr Child Health 2003; 8(9):577-8. doi: 10.1093/pch/8.9.577.
  10. Mayer-Davis EJ, Kahkoska AR, Jefferies C, Dabelea D, Balde N, Gong CX, et al. ISPAD clinical practice consensus guidelines 2018: Definition, epidemiology, and classifi-cation of diabetes in children and adolescents. Pediatr Diabetes 2018; 19(Suppl 27):7-19. doi: 10.1111/pedi. 12773.
  11. Scottish Study Group for the Care of the Young Diabetic. Factors influencing glycaemic control in young people with Type I Diabetes in Scotland: A population-based study (DIABAUD2). Diabetes Care 2001; 24(2):239-44. doi: 10. 2337/diacare.24.2.239.
  12. Dumrisilp T, Supornsilchai V, Wacharasindhu S, Aroonpar-kmongkol S, Sahakitrungruang T. Factors associated with glycaemic control in children and adolescents with type 1 diabetes mellitus at a tertiary-care center in Thailand: A retrospective observational study. Asian Biomed 2017; 11(6):443-50. doi: 10.1515/abm-2018-0021.
  13. McLarty RP, Alloyce JP, Chitema GG, Msuya LJ. Glycaemic control, associated factors, acute complications of type I diabetes mellitus in children, adolescents and young adults in Tanzania. Endocrinol Diabetes Metab 2021; 4(2): e00200. doi: 10.1002/edm2.200.
  14. Rosilio M, Cotton JB, Wieliczko MC, Gendrault B, Carel JC, Couvaras O, et al. Factors associated with glycaemic control: A cross-sectional nationwide study in 2,579 French children with type I diabetes. Diabetes Care 1998; 21(7): 1146-53. doi: 10.2337/diacare.21.7.1146.
  15. Kitzler T, Bachar M, Skrabal F, Kotanko P. Evaluation of treatment adherence in type I diabetes: A novel approach. Eur J Clin Invest 2007; 37(3):207-13. doi: 10.1111/j.1365- 2362.2007.01771.x.
  16. Kaufman FR, Halvorson M, Carpenter S. Association between diabetes control and visits to a multidisciplinary paediatric diabetes clinic. Paediatrics 1999; 103(5 Pt 1):948-51. doi: 10.1542/peds.103.5.948.
  17. Rubelj K, Stipancic G, La Sabolic LG, Sepec MP. Continuous glucose monitoring and type I diabetes mellitus control in child, adolescent and young adult population–arguments for its use and effects. Acta Clin Croat 2021; 60(4):609-15. doi: 10.20471/acc.2021.60.04.07.